Novel strategies to target the ubiquitin proteasome system in multiple myeloma

Multiple myeloma (MM) is a hematological malignancy characterized by the accumulation of plasma cells in the bone marrow (BM). The success of the proteasome inhibitor bortezomib in the treatment of MM highlights the importance of the ubiquitin proteasome system (UPS) in this particular cancer. Despi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lub, Susanne, Maes, Ken, Menu, Eline, De Bruyne, Elke, Vanderkerken, Karin, Van Valckenborgh, Els
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872730/
https://www.ncbi.nlm.nih.gov/pubmed/26695547
http://dx.doi.org/10.18632/oncotarget.6658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872730/
https://www.ncbi.nlm.nih.gov/pubmed/26695547
http://dx.doi.org/10.18632/oncotarget.6658

Ejemplares similares